Nucleai develops AI models to analyse pathology slides and identify pre-cancerous markers. Co-founded by researchers from University of Melbourne and Royal Melbourne Hospital, the startup is in pilots with three major Australian pathology networks. Their algorithm outperforms human annotation on melanoma and colorectal samples.